Roche’s Accu-Chek Connect Diabetes Management App has hit yet another snag with the FDA. On February 15, the agency issued a Class 2 Device Recall for certain software versions of the app due to a bug ...
BASEL, Switzerland, Sept. 16, 2025 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) shared real-world evidence from the rollout of Accu-Chek SmartGuide continuous glucose monitoring (CGM) solution ...
Please provide your email address to receive an email when new articles are posted on . The FDA recently announced a recall of Roche Diabetes Care Inc.’s Accu-Chek Connect Diabetes Management App due ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results